Literature DB >> 24162659

The rheostat in the membrane: BCL-2 family proteins and apoptosis.

N Volkmann1, F M Marassi2, D D Newmeyer3, D Hanein1.   

Abstract

Apoptosis, a mechanism for programmed cell death, has key roles in human health and disease. Many signals for cellular life and death are regulated by the BCL-2 family proteins and converge at mitochondria, where cell fate is ultimately decided. The BCL-2 family includes both pro-life (e.g. BCL-XL) and pro-death (e.g. BAX, BAK) proteins. Previously, it was thought that a balance between these opposing proteins, like a simple 'rheostat', could control the sensitivity of cells to apoptotic stresses. Later, this rheostat concept had to be extended, when it became clear that BCL-2 family proteins regulate each other through a complex network of bimolecular interactions, some transient and some relatively stable. Now, studies have shown that the apoptotic circuitry is even more sophisticated, in that BCL-2 family interactions are spatially dynamic, even in nonapoptotic cells. For example, BAX and BCL-XL can shuttle between the cytoplasm and the mitochondrial outer membrane (MOM). Upstream signaling pathways can regulate the cytoplasmic-MOM equilibrium of BAX and thereby adjust the sensitivity of cells to apoptotic stimuli. Thus, we can view the MOM as the central locale of a dynamic life-death rheostat. BAX invariably forms extensive homo-oligomers after activation in membranes. However, recent studies, showing that activated BAX monomers determine the kinetics of MOM permeabilization (MOMP), perturb the lipid bilayer and form nanometer size pores, pose questions about the role of the oligomerization. Other lingering questions concern the molecular mechanisms of BAX redistribution between MOM and cytoplasm and the details of BAX/BAK-membrane assemblies. Future studies need to delineate how BCL-2 family proteins regulate MOMP, in concert with auxiliary MOM proteins, in a dynamic membrane environment. Technologies aimed at elucidating the structure and function of the full-length proteins in membranes are needed to illuminate some of these critical issues.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24162659      PMCID: PMC3890954          DOI: 10.1038/cdd.2013.153

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  113 in total

1.  NMR structural investigation of the mitochondrial outer membrane protein VDAC and its interaction with antiapoptotic Bcl-xL.

Authors:  Thomas J Malia; Gerhard Wagner
Journal:  Biochemistry       Date:  2007-01-16       Impact factor: 3.162

2.  Heat-induced dimerization of BCL-xL through alpha-helix swapping.

Authors:  Alexey Yu Denisov; Tara Sprules; James Fraser; Guennadi Kozlov; Kalle Gehring
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

Review 3.  Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes.

Authors:  Brian Leber; Jialing Lin; David W Andrews
Journal:  Apoptosis       Date:  2007-05       Impact factor: 4.677

4.  Structural model of the BCL-w-BID peptide complex and its interactions with phospholipid micelles.

Authors:  Alexey Yu Denisov; Gang Chen; Tara Sprules; Tudor Moldoveanu; Pierre Beauparlant; Kalle Gehring
Journal:  Biochemistry       Date:  2006-02-21       Impact factor: 3.162

5.  BCL-XL dimerization by three-dimensional domain swapping.

Authors:  Jason W O'Neill; Michael K Manion; Brendan Maguire; David M Hockenbery
Journal:  J Mol Biol       Date:  2005-12-01       Impact factor: 5.469

6.  Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis.

Authors:  Matthew G Annis; Erinn L Soucie; Paulina J Dlugosz; Jorge A Cruz-Aguado; Linda Z Penn; Brian Leber; David W Andrews
Journal:  EMBO J       Date:  2005-05-26       Impact factor: 11.598

7.  Loss of Bif-1 suppresses Bax/Bak conformational change and mitochondrial apoptosis.

Authors:  Yoshinori Takahashi; Mariusz Karbowski; Hirohito Yamaguchi; Aslamuzzaman Kazi; Jie Wu; Saïd M Sebti; Richard J Youle; Hong-Gang Wang
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

8.  Peptides corresponding to helices 5 and 6 of Bax can independently form large lipid pores.

Authors:  Ana J García-Sáez; Manuela Coraiola; Mauro Dalla Serra; Ismael Mingarro; Peter Müller; Jesús Salgado
Journal:  FEBS J       Date:  2006-03       Impact factor: 5.542

Review 9.  Bcl-2-regulated apoptosis: mechanism and therapeutic potential.

Authors:  Jerry M Adams; Suzanne Cory
Journal:  Curr Opin Immunol       Date:  2007-07-12       Impact factor: 7.486

10.  GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation.

Authors:  Anna Colell; Jean-Ehrland Ricci; Stephen Tait; Sandra Milasta; Ulrich Maurer; Lisa Bouchier-Hayes; Patrick Fitzgerald; Ana Guio-Carrion; Nigel J Waterhouse; Cindy Wei Li; Bernard Mari; Pascal Barbry; Donald D Newmeyer; Helen M Beere; Douglas R Green
Journal:  Cell       Date:  2007-06-01       Impact factor: 41.582

View more
  77 in total

1.  Imbalanced expression of Bcl-xL and Bax in platelets treated with plasma from immune thrombocytopenia.

Authors:  Jianlin Qiao; Yun Liu; Depeng Li; Yulu Wu; Xiaoqian Li; Yao Yao; Mingshan Niu; Chunling Fu; Hongchun Li; Ping Ma; Zhenyu Li; Kailin Xu; Lingyu Zeng
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

2.  BH3-in-groove dimerization initiates and helix 9 dimerization expands Bax pore assembly in membranes.

Authors:  Zhi Zhang; Sabareesh Subramaniam; Justin Kale; Chenyi Liao; Bo Huang; Hetal Brahmbhatt; Samson G F Condon; Suzanne M Lapolla; Franklin A Hays; Jingzhen Ding; Feng He; Xuejun C Zhang; Jianing Li; Alessandro Senes; David W Andrews; Jialing Lin
Journal:  EMBO J       Date:  2015-12-23       Impact factor: 11.598

3.  Conformational Heterogeneity in the Activation Mechanism of Bax.

Authors:  C Ashley Barnes; Pushpa Mishra; James L Baber; Marie-Paule Strub; Nico Tjandra
Journal:  Structure       Date:  2017-07-14       Impact factor: 5.006

Review 4.  Sarcoplasmic reticulum-mitochondria communication in cardiovascular pathophysiology.

Authors:  Camila Lopez-Crisosto; Christian Pennanen; Cesar Vasquez-Trincado; Pablo E Morales; Roberto Bravo-Sagua; Andrew F G Quest; Mario Chiong; Sergio Lavandero
Journal:  Nat Rev Cardiol       Date:  2017-03-09       Impact factor: 32.419

Review 5.  BCL-2 family: integrating stress responses at the ER to control cell demise.

Authors:  Philippe Pihán; Amado Carreras-Sureda; Claudio Hetz
Journal:  Cell Death Differ       Date:  2017-06-16       Impact factor: 15.828

6.  Anticancer activities of alkaloids extracted from the Ba lotus seed in human nasopharyngeal carcinoma CNE-1 cells.

Authors:  Xin Zhao; Xia Feng; Deguang Peng; Weiwei Liu; Peng Sun; Guijie Li; Lianjie Gu; Jia-Le Song
Journal:  Exp Ther Med       Date:  2016-09-20       Impact factor: 2.447

Review 7.  Molecular strategies used by hibernators: Potential therapeutic directions for ischemia reperfusion injury and preservation of human donor organs.

Authors:  E Soo; A Welch; C Marsh; D B McKay
Journal:  Transplant Rev (Orlando)       Date:  2019-10-18       Impact factor: 3.943

8.  Endolysosomal Targeting of Mitochondria Is Integral to BAX-Mediated Mitochondrial Permeabilization during Apoptosis Signaling.

Authors:  Tim Sen Wang; Isabelle Coppens; Anna Saorin; Nathan Ryan Brady; Anne Hamacher-Brady
Journal:  Dev Cell       Date:  2020-06-05       Impact factor: 12.270

9.  DZNep represses Bcl-2 expression and modulates apoptosis sensitivity in response to Nutlin-3a.

Authors:  Yalu Zhou; Ricardo E Perez; Lei Duan; Carl G Maki
Journal:  Cancer Biol Ther       Date:  2018-03-13       Impact factor: 4.742

Review 10.  Small molecule Mcl-1 inhibitors for the treatment of cancer.

Authors:  Johannes Belmar; Stephen W Fesik
Journal:  Pharmacol Ther       Date:  2014-08-27       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.